Morocco pledges USD5M to Gavi, becoming the major North African donor

MOROCCO— The kingdom of Morocco has pledged USD5 million to support Gavi, the Vaccine Alliance, for its upcoming strategic period from 2026 to 2030.

This marks Morocco’s first-ever financial contribution to Gavi and represents the largest commitment made by any North African country.

This pledge highlights Morocco’s increasing leadership in global health security, particularly its efforts to boost regional vaccine production and support African-led development initiatives.

It also demonstrates the country’s determination to advance global solidarity while amplifying Africa’s voice in international forums.

The commitment aligns closely with the vision of His Majesty King Mohammed VI, Allah nasarahu, who envisions an emerging, united, and resilient Africa—driven by shared progress, cooperative development, and solidarity.

Furthermore, Morocco’s pledge reflects its long-standing dedication to South-South cooperation and its growing role as a bridge between Africa and the broader global community on health and sustainable development issues.

Mr. Amine Tehraoui, Morocco’s Minister of Health and Social Protection, underscored that the royal vision inspires the pledge.

He emphasized that this donation marks Morocco’s entry as a donor to Gavi and reflects the shared conviction that investing in vaccines is vital for the continent’s future stability and prosperity.

Drawing lessons from the recent pandemic, Mr. Tehraoui reiterated Morocco’s commitment to strengthening immunization through international solidarity and co-development, ensuring every child’s right to protection and opportunity.

Morocco’s unwavering belief is clear: no child worldwide should lack access to life-saving vaccines.

H.E. Nadia Fettah Alaoui, Minister of Economy and Finance, stated that the pledge forms part of Morocco’s fruitful ongoing cooperation with Gavi.

It underscores their commitment to global initiatives that promote equitable and sustainable access to vaccines, especially for vulnerable groups.

Dr. Sania Nishtar, CEO of Gavi, warmly welcomed Morocco as the alliance’s newest donor.

She noted that 80 percent of Gavi’s resources for the next strategic period will be allocated to Africa, where Morocco’s leadership will play a key role in immunization initiatives.

During a recent visit, Dr. Nishtar praised King Mohammed VI’s strategic vision for vaccine manufacturing on the continent, calling it a model for other countries.

Morocco’s pledge is timely, as Gavi prepares to implement its next strategic phase, known as “Gavi 6.0,” which aims to protect 500 million children between 2026 and 2030. Africa remains central to Gavi’s efforts during this period.

Immunization ranks among the most impactful and cost-effective public health investments worldwide, saving an estimated 4-5 million lives annually while preventing illness and disability.

For every dollar invested, Gavi yields a remarkable USD 54 return through healthier populations, lower healthcare costs, and stronger economies.

Additionally, Gavi’s next strategic phase will incorporate the ambitious reform platform “Gavi Leap,” designed to enhance country ownership, sovereignty, and self-reliance.

This initiative promotes equal partnerships, co-investment, agency collaboration, and alignment with national development priorities.

Morocco’s contribution coincides with the country’s accelerated efforts to become a regional hub for vaccine manufacturing.

It is building a robust ecosystem that fosters vaccine innovation, production, and health security.

The pledge underscores Morocco’s strategic ambition for an Africa that produces, innovates, and leads in global health, rather than simply receiving external solutions.

As a public-private partnership, Gavi collaborates with lower-income countries to pool demand, secure affordable vaccines, and invest in health systems.

Morocco’s donation reinforces this model, showcasing how regional leadership can translate foreign policy into meaningful support for equitable access to vaccines worldwide.